menu
    • menu

    Company profile for Georgiamune

    NEW Drugs in Dev: 4
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Georgiamune Inc. is a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Unique approaches to re-establishing immune balance and groundbreaking scientific discoveries have led to the development of pioneering immune therapeutics for cancer and autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GeorgiamuneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    942 Clopper Rd Gaithersburg, MD 20878
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.georgiamune.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/georgiamune/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Georgiamune Appoints Mark Avagliano As Chief Business Officer
    Georgiamune Appoints Mark Avagliano As Chief Business Officer

    19 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/19/2983651/0/en/Georgiamune-Appoints-Biopharma-Veteran-Mark-Avagliano-as-Chief-Business-Officer-to-Drive-Growth.html

    GLOBENEWSWIRE
    19 Nov 2024
    Share Share
    Georgiamune Doses First Participant in GIM-407 Phase 1 Trial
    Georgiamune Doses First Participant in GIM-407 Phase 1 Trial

    24 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/24/2952226/0/en/Georgiamune-Announces-First-Participant-Dosed-in-First-In-Class-Phase-1-Healthy-Volunteers-Trial-of-GIM-407.html

    GLOBENEWSWIRE
    24 Sep 2024
    Share Share
    Georgiamune Doses First Patient In Phase 1 GIM-531 Cancer Trial
    Georgiamune Doses First Patient In Phase 1 GIM-531 Cancer Trial

    30 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/30/2921055/0/en/Georgiamune-Announces-First-Patient-Dosed-in-A-First-In-Class-Phase-1-Cancer-Treatment-Trial-of-GIM-531.html

    GLOBENEWSWIRE
    30 Jul 2024
    Share Share
    Georgiamune Adds 2 Novel Cancer Drugs In 5 Months
    Georgiamune Adds 2 Novel Cancer Drugs In 5 Months

    29 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/29/2889954/0/en/Georgiamune-Expands-Cancer-Treatment-Pipeline-with-Two-Novel-Drugs-Within-Five-Months-of-Launch.html

    GLOBENEWSWIRE
    29 May 2024
    Share Share
    Georgiamune Expands Pipeline With 2 New Cancer Drugs In 5 Months
    Georgiamune Expands Pipeline With 2 New Cancer Drugs In 5 Months

    29 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/29/2890045/0/en/UPDATE-Georgiamune-Expands-Cancer-Treatment-Pipeline-with-Two-Novel-Drugs-Within-Five-Months-of-Launch.html

    GLOBENEWSWIRE
    29 May 2024
    Share Share
    Georgiamune and Verily Announce Partnership to Advance Novel Cancer Treatment
    Georgiamune and Verily Announce Partnership to Advance Novel Cancer Treatment

    26 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231026188040/en

    BUSINESSWIRE
    26 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search